NCT02201693 Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease Status COMPLETED Phase NA
NCT02199561 Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02197780 Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD Status COMPLETED Phase N/A
NCT02193802 Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease Status UNKNOWN Phase NA
NCT02193750 Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease Status TERMINATED Phase NA
NCT02193048 Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease Status COMPLETED Phase N/A
NCT02185183 Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase PHASE1/PHASE2
NCT02185014 Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115 Status COMPLETED Phase PHASE3
NCT02179372 Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases Status COMPLETED Phase NA
NCT02177071 A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy Status COMPLETED Phase PHASE4
NCT02164877 Effect of Soluble Dietary Fiber on Bacterial Translocation in Crohn's Disease Status TERMINATED Phase PHASE2
NCT02154425 A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers Status COMPLETED Phase PHASE1
NCT02148185 Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease Status COMPLETED Phase PHASE1
NCT02130362 A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02096861 Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT02087878 A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma Status WITHDRAWN Phase N/A